Sun Pharma Stock Hits Rough Patch Amid Profit Slump

Sun Pharmaceutical Industries experienced a sharp decline in stock value after reporting a 20% drop in consolidated net profit for Q1 2025. Despite a rise in total income and adjusted net profits, the company's shares fell nearly 6%, extending a previous decrease.

Shares of Sun Pharmaceutical Industries took a nosedive on Friday, dropping nearly 6% following the announcement of a 20% year-on-year decline in consolidated net profit for the first quarter ending June 30, 2025.

Continuing its downward trend from the previous day, Sun Pharma's stock plummeted 5.70% to Rs 1,608.30 on the BSE and by 5.78% to Rs 1,608 on the NSE.

The company, headquartered in Mumbai, reported a net profit of Rs 2,279 crore, a significant drop from Rs 2,836 crore in the same quarter the previous year, despite an increase in adjusted net profit and total income.